Concepedia

Mayumi Saki

MS

Statistics

Publications

8

Citations

233

H-Index

8

Active since

2002

Affiliations

Kyowa Kirin (Japan)(Current)

Mayumi Saki is an author at Kyowa Kirin (Japan) specializing in pharmacology, adenosine receptor signaling, and receptor pharmacology.

Publications per year

2002–2023

8

Publications

8

Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan

Makio Takahashi, Masaki Fujita, Naoko Asai et al. · Expert Opinion on Pharmacotherapy · 2018 · 54 citations

, , +17

In vitro pharmacological profile of the A2A receptor antagonist istradefylline

Mayumi Saki, Koji Yamada, Etsuko Koshimura et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2013 · 48 citations

, , +7

Synthetic studies on selective adenosine A2A receptor antagonists: Synthesis and structure–activity relationships of novel benzofuran derivatives

Osamu Saku, Mayumi Saki, Masako Kurokawa et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 41 citations

, , +13

KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist

Mayumi Saki, Hiroshi Tsumuki, Hiromi Nonaka et al. · European Journal of Pharmacology · 2002 · 28 citations

, , +4

In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2A Receptor Antagonist/Inverse Agonist

Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada et al. · Molecular Pharmacology · 2023 · 17 citations

, , +17

1–5 of 8